ÂÜÀòÂÒÂ×

Dr. Gina Eagle, MD joined Vivtex in June 2022, with over 32 years of experience in clinical practice and research, particularly in the areas of infectious disease and orphan indications. She served in multiple clinical development leadership roles in the clinical development of oritavancin for acute bacterial skin and skin structure infections at The Medicines Company and Arikayce for Mycobacterium avium Complex (MAC) lung infections at Insmed. Dr. Eagle received her medical degree with Honors from the University of New South Wales, Australia, and specialized in pediatric medicine and is a Fellow of the Australasian College of Physicians. She worked as a specialist pediatrician in Australia and the UK before joining the pharmaceutical industry 17 years ago, working in medical affairs and marketing, prior to focusing on clinical development.